Down syndrome--recent progress and future prospects
Open Access
- 15 April 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 18 (R1) , R75-R83
- https://doi.org/10.1093/hmg/ddp010
Abstract
Down syndrome (DS) is caused by trisomy of chromosome 21 (Hsa21) and is associated with a number of deleterious phenotypes, including learning disability, heart defects, early-onset Alzheimer's disease and childhood leukaemia. Individuals with DS are affected by these phenotypes to a variable extent; understanding the cause of this variation is a key challenge. Here, we review recent research progress in DS, both in patients and relevant animal models. In particular, we highlight exciting advances in therapy to improve cognitive function in people with DS and the significant developments in understanding the gene content of Hsa21. Moreover, we discuss future research directions in light of new technologies. In particular, the use of chromosome engineering to generate new trisomic mouse models and large-scale studies of genotype–phenotype relationships in patients are likely to significantly contribute to the future understanding of DS.Keywords
This publication has 136 references indexed in Scilit:
- A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehogMechanisms of Development, 2008
- Genotype–phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21European Journal of Human Genetics, 2008
- DYRK1A-Dosage Imbalance Perturbs NRSF/REST Levels, Deregulating Pluripotency and Embryonic Stem Cell Fate in Down SyndromeAmerican Journal of Human Genetics, 2008
- The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndromeActa Neuropathologica, 2008
- RETRACTED: Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and heartsBiochemical and Biophysical Research Communications, 2008
- Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndromeNeuroscience Letters, 2007
- Differential effects of trisomy on brain shape and volume in related aneuploid mouse modelsAmerican Journal of Medical Genetics Part A, 2007
- MNB/DYRK1A phosphorylation regulates the interactions of synaptojanin 1 with endocytic accessory proteinsBiochemical and Biophysical Research Communications, 2006
- Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brainNeurobiology of Aging, 2006
- NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21Nature, 2006